![]() |
市场调查报告书
商品编码
1708242
皮肤科准分子雷射市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测Dermatology Excimer Laser Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球皮肤科准分子雷射市场规模达 6.096 亿美元,预计 2025 年至 2034 年期间的复合年增长率为 10.2%。这些高度专业化的医疗设备使用高强度紫外线光束针对特定的皮肤区域,提供卓越的精确度,同时将对周围组织的损伤降至最低。准分子雷射的工作波长为 308 奈米,是治疗各种皮肤病的理想选择。随着皮肤病患病率的不断上升,特别是牛皮癣、白斑症和湿疹等皮肤病,对准分子雷射的需求显着增长。技术进步提高了这些雷射的效率和精度,进一步推动了这一上升趋势。现在,越来越多的医疗保健提供者和患者开始采用准分子雷射来寻求有效的非侵入性治疗选择。因此,准分子雷射已成为现代皮肤病学的重要工具,为需要高精度治疗的皮肤病提供可靠且有针对性的解决方案。
市场分为几个类别,包括推车式、手持式和桌上型准分子雷射。 2024年,推车式准分子雷射占45.6%的市占率。这些设备因其结构坚固、便于携带以及能够将 UVB 光准确地传送到皮肤的特定区域而备受青睐。该领域的成长可以归因于雷射设备的技术进步和对皮肤状况的深入了解,这使得推车式准分子雷射成为各种皮肤病治疗的首选解决方案。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 6.096亿美元 |
预测值 | 16亿美元 |
复合年增长率 | 10.2% |
在应用方面,准分子雷射市场根据所治疗的皮肤状况进一步细分。例如,牛皮癣在 2024 年占据了 38.2% 的市场。准分子雷射在治疗牛皮癣病变方面特别有效,可将 UVB 光直接传送到患处,从而促进更快的癒合和恢復。随着对慢性皮肤病有效治疗的需求不断增长,准分子雷射越来越被认可为患者和医疗保健提供者的首选。
2024 年美国皮肤科准分子雷射市场规模达 2.287 亿美元,预计复合年增长率为 10.2%。慢性皮肤病的激增,加上提高效率和安全性的雷射技术的进步,刺激了美国市场的成长。准分子雷射治疗具有针对性、非侵入性、精确性和有效性,使其成为解决该地区各种皮肤病问题的首选。随着该市场的不断发展,准分子雷射将在未来的皮肤病治疗中发挥关键作用。
The Global Dermatology Excimer Laser Market generated USD 609.6 million in 2024 and is expected to grow at a CAGR of 10.2% between 2025 and 2034. These highly specialized medical devices use high-intensity ultraviolet light beams to target specific skin areas, offering exceptional precision with minimal damage to surrounding tissue. Operating at a wavelength of 308 nanometers, excimer lasers are ideal for treating various skin conditions. With the increasing prevalence of skin disorders, particularly in dermatological cases like psoriasis, vitiligo, and eczema, the demand for excimer lasers has seen significant growth. Technological advancements, which have enhanced the efficiency and precision of these lasers, have only fueled this upward trend. More healthcare providers and patients are now turning to excimer lasers for effective, non-invasive treatment options. As a result, excimer lasers have become an essential tool in modern dermatology, offering reliable and targeted solutions for skin conditions that require a high degree of precision in treatment.
The market is segmented into several categories, including excimer lasers such as trolley-mounted, handheld, and tabletop devices. In 2024, trolley-mounted excimer lasers accounted for a 45.6% market share. These devices are highly favored due to their robust construction, ease of transport, and ability to deliver UVB light accurately to specific areas of the skin. The growth of this segment can be attributed to both technological advancements in laser equipment and an enhanced understanding of skin conditions, which have made trolley-mounted excimer lasers the go-to solution for a variety of dermatological treatments.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $609.6 Million |
Forecast Value | $1.6 Billion |
CAGR | 10.2% |
In terms of application, the excimer laser market is further divided by the skin conditions being treated. Psoriasis, for example, made up 38.2% of the market share in 2024. Excimer lasers are particularly effective in treating psoriasis lesions, delivering UVB light directly to the affected areas, thereby promoting faster healing and recovery. As the demand for effective treatments for chronic skin disorders continues to rise, excimer lasers are increasingly recognized as a go-to option for patients and healthcare providers alike.
The U.S. Dermatology Excimer Laser Market generated USD 228.7 million in 2024 and is expected to grow at a 10.2% CAGR. The surge in chronic skin conditions, coupled with advancements in laser technology that enhance both efficiency and safety, has spurred the market's growth in the U.S. The targeted, non-invasive nature of excimer laser treatments, which offer both precision and effectiveness, has made them the preferred choice for addressing a wide range of dermatological issues in the region. As this market continues to evolve, excimer lasers are set to play a crucial role in the future of dermatology treatments.